Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpoints. Cannon AC, Budagyan K, Uribe-Alvarez C, Kurimchak AM, et al. Oncogene 2024 Jan 19. doi: 10.1038/s41388-024-02947.

Read + Share

Amedeo Smart

Independent Medical Education

Cannon AC, Budagyan K, Uribe-Alvarez C, Kurimchak AM, et al. Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpoints. Oncogene 2024 Jan 19. doi: 10.1038/s41388-024-02947.
PMID: 38243078